阿米卡星硫酸鹽(5:9)
| 中文名稱 | 阿米卡星硫酸鹽(5:9) |
|---|---|
| 中文同義詞 | 阿米卡霉素硫酸;磺胺甲惡唑149022-22-0;硫酸阿米卡星149022-22-0;硫酸阿米卡星;硫酸阿米卡星(5:9);O-3-氨基-3-脫氧-Α-D-吡喃葡萄糖基-(1→6)-O-[6-氨基-6-脫氧-Α-D-吡喃葡萄糖基-(1→4)]-N1-[(2S)-4-氨基-2-羥基-1-氧丁基]-2-脫氧-D-鏈胺硫酸鹽(5:9);阿米卡星硫酸鹽(5:9);(S)-4-氨基-N-((1R,2S,3S,4R,5S)-5-氨基-2-(((2S,3R,4S,5S,6R)-4-氨基-3,5-二羥基-6-(羥甲基)四氫-2H-吡喃-2-基)氧基)-4-(((2R,3R,4S,5S,6R)-6-(氨基甲基)-3,4,5-三羥基四氫-2H-吡喃-2-基)氧基)-3-羥基環(huán)己基)-2-羥基丁酰胺硫酸鹽(5:9) |
| 英文名稱 | Amikacin sulfate salt |
| 英文同義詞 | AMIKACIN SULFATE 1:1.8;Amikacin sulfate salt;(2S)-4-AMino-N-{(1R,2S,3S,4R,5S)-5-aMino-2-[(3-aMino-3-deoxy-a-D-glucopyranosyl)oxy]-4-[(6-aMino-6-deoxy-a-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanaMide sulfate (1:2);AMIKASIN SULFATE;AMIKACIN SULFATE SALT, AMINOGLYCOSID;Amikacin sulfate(5:9);mikacin disulfate salt;liusuanamukaxonm |
| CAS號 | 149022-22-0 |
| 分子式 | C22H45N5O17S |
| 分子量 | 683.68 |
| EINECS號 | 254-648-6 |
| 相關(guān)類別 | 醫(yī)藥原料;抗感染藥物;醫(yī)藥與生物化工;原料藥;化合物：原料藥;醫(yī)藥獸藥;醫(yī)藥原料藥-科研原料;中間體;原料中間體-原料藥;精細(xì)化工;醫(yī)用原料;醫(yī)用原料;獸藥原料藥;APIs;飼料添加劑;獸藥原料;抗生素類;化學(xué)原料 |
| Mol文件 | 149022-22-0.mol |
| 結(jié)構(gòu)式 |  |
阿米卡星硫酸鹽(5:9) 性質(zhì)
| 儲存條件 | Inert atmosphere,2-8°C |
|---|---|
| 溶解度 | H2O中可溶50mg/mL |
| 形態(tài) | 固體 |
| 顏色 | 白色至類白色 |
| 生物來源 | synthetic |
| InChIKey | HIBICIOPDUTNRR-BOEHXBESSA-N |
Amikacin offers definite advantages for treating infections caused by organisms resistant to other aminoglycosides. Amikaci is affected by relatively few arninoglycoside-modifying enzymes. Amikacin is useful in the treatment of infections caused by
Nocardia asteroides
,
Mycobacterium avium-intracellulare
, and certain species of "rapid-growing" mycobacteria (that is,
M. chelonae
and
M. fortuitumi
).
Amikacin (100-1500 μM) causes a reliable dose-dependent loss of lateral line zebrafish hair cells with a LD
50
value of 453 μM.
Amikacin (320?mg/kg; subcutaneous injection; daily; for 10 days; male Fischer rats) treatment increases the chance of serious hearing loss in rats in vivo.
| Animal Model: | Male Fischer 344 rats (40-50-day-old) |
| Dosage: | 320?mg/kg |
| Administration: | Subcutaneous injection; daily; for 10 days |
| Result: | Induced hearing loss in rats. |
安全信息
| WGK Germany | 2 |
|---|---|
| RTECS號 | WK1961200 |